ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
JHS Svendgaard filed its quarterly Regulation 32 statement on 2024 preferential issue proceeds. Fund allocation shifted toward capex after shareholder approval; no quarter deviation reported.
JHS Svendgaard Laboratories appointed Mr. Pardeep Kumar Bhardwaj as a Non-Executive Independent Director, effective 2 November 2026, for five years, subject to shareholder approval. Board committee compositions were also reconstituted.
JHS Svendgaard Laboratories Ltd reported revenue from operations of ₹21.8 Cr (-2.2% YoY) and net profit of ₹0.5 Cr for Q2 FY27.
JHS Svendgaard Laboratories has intimated a Board meeting on 2 November 2026 to approve un-audited Q1/H1 FY27 results. Trading window closed from 1 October 2026.
JHS Svendgaard Laboratories Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of SEBI LODR Regulations for the quarter ended September 30, 2026.
JHS Svendgaard Laboratories held its 22nd Annual General Meeting on September 26, 2026, transacting business related to financial statements and director appointment.
JHS Svendgaard Labs filed a Reg 36(1)(b) letter sending web-links and QR codes for its 2025-26 Annual Report to unregistered shareholders. No transaction, board decision, or business event is involved.
JHS Svendgaard Laboratories Ltd will hold its 22nd Annual General Meeting on September 26, 2026. Shareholders will consider financial statements and director re-appointment.
JHS Svendgaard Laboratories Limited has filed its Integrated Annual Report for the Financial Year 2025-26, including notice for the 22nd Annual General Meeting.